The Evolution of an Allogeneic Process; from Research to Clinical Trials and Commercialization

Time: 3:30 pm
day: Track B - Day 1 - 3PM

Details:

• Keeping process development aligned with clinical data
• Review regulatory and commercial considerations
• Describe the Target Process Profile; engineering desirable characteristics

Speakers: